Pharmacokinetics of oxytetracycline and therapeutic implications in veal calves
- 1 December 1982
- journal article
- research article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 5 (4), 247-257
- https://doi.org/10.1111/j.1365-2885.1982.tb00440.x
Abstract
Pharmacokinetic parameters of oxytetracycline were analysed in healthy preruminant veal calves after intravenous, intramuscular and oral administration. The serum half-lives in the beta-elimination phase of both 10% and 20% solutions after i.v. injection of 10 mg/kg were similar (7.07 +/- 1.36 h and 7.16 +/- 1.17 h, mean +/- SD), whereas the total body clearance and the apparent volume of distribution were higher for the 20% solution. Serum concentrations above 0.5 microgram/ml were maintained with both formulations during 12-24 h but were only above 4 micrograms/ml to 5 h. Intramuscular administration of the 20% solution gave a complete absorption with two rate constants of absorption, a faster (t1/2 alpha 1 = 0.27 h) and a slower one (t1/2 alpha 2 = 10.90 h) responsible for the delayed elimination half-life after this route of application (t1/2 beta = 9.83 +/- 1.35 h). Mean serum concentrations reached a maximum level of 3.01 +/- 0.72 micrograms/ml at 4.01 +/- 2.84 h and decreased to 0.5 microgram/ml between 12 and 24 h. 50 mg/kg given orally with a milk replacer were found to have a mean bioavailability of 46.35%. A mean serum peak level of 4.99 +/- 1.37 micrograms/ml was achieved at 9.16 +/- 1.99 h and the mean concentration was still above 0.5 microgram/ml after 48 h. The elimination half-life (t1/2 beta = 10.66 +/- 3.15 h) reflected the slow absorption step (t1/2 alpha 2 = 10.15 h) following that responsible for the initial faster absorption (t1/2 alpha 1 = 1.99 h). Comparison of the area under the serum curves gave mean values of 117% for tetracycline and of 53% for chlortetracycline relative to oxytetracycline (arbitrarily fixed at 100%) after identical oral dosage of the three tetracyclines. We also propose and discuss a dosage schedule based on minimal inhibitory concentrations of different susceptible pathogens.Keywords
This publication has 16 references indexed in Scilit:
- Postantibiotic Suppression of Bacterial GrowthClinical Infectious Diseases, 1981
- Postantibiotic Leukocyte Enhancement: Increased Susceptibility of Bacteria Pretreated with Antibiotics to Activity of LeukocytesClinical Infectious Diseases, 1981
- Volume terms in pharmacokineticsPublished by Springer Nature ,1980
- Recovery Period and the Exposure of Bacteria to Subminimal Inhibitory Concentrations of Antibiotics*Clinical Infectious Diseases, 1979
- Tetracyclines and Host Defense Mechanisms: Interference with Leukocyte ChemotaxisScandinavian Journal of Infectious Diseases, 1979
- Factors Affecting Serum Oxytetracycline Levels in Beef CalvesJournal of Pharmaceutical Sciences, 1977
- Persistent Effect of Antibiotics on Staphylococcus aureus after Exposure for Limited Periods of TimeThe Journal of Infectious Diseases, 1977
- The Role of the Therapeutic Regimen in Dosage Design. Part IChemotherapy, 1965
- Kinetic Analysis of Blood Levels and Urinary Excretion in the Absorptive Phase after Single Doses of DrugJournal of Pharmaceutical Sciences, 1964
- Per Cent Absorbed Time Plots Derived from Blood Level and/or Urinary Excretion DataJournal of Pharmaceutical Sciences, 1963